Agios Pharmaceuticals | AGIO - Zobowiązania





Zobowiązania Zmiana Data
AbbVie USD 43.1B 1.46B 2026-09
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Alnylam Pharmaceuticals USD 2.06B 550.49M 2026-09
Amgen USD 23.23B 2.27B 2026-09
Arrowhead Research USD 283.35M 11.87M 2026-06
Astellas Pharma JPY 1.1T 134.96B 2026-09
AstraZeneca USD 31.27B 286M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Biogen USD 3.9B 18.7M 2026-09
BioMarin Pharmaceutical USD 1.6B 59.17M 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Daiichi Sankyo JPY 882.78B 117.08B 2026-09
Eli Lilly USD 47B 745M 2026-09
Exelixis USD 411.88M 49.95M 2026-09
Gilead Sciences USD 12B 982M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
Incyte USD 1.44B 125.72M 2026-09
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Merck USD 27.73B 786M 2026-06
Moderna USD 2.53B 139M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 32.52B 777M 2026-09
Novartis USD 32.52B 1.15B 2026-09
Pfizer USD 31.73B 920M 2026-09
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 6.2B 671.5M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sarepta Therapeutics USD 502.91M 3.74M 2026-06
Vertex Pharmaceuticals USD 5B 1.06B 2026-09